Citius Pharmaceuticals, Inc. (CTXR) Total assets 2017–2022
Citius Pharmaceuticals, Inc. (CTXR) total assets at each fiscal year-end, per SEC filings.
$114.0MFY2022 · since FY2017: $24.4M → $114.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $114.0M | -20.0% |
| FY2021 | $142.4M | +225.4% |
| FY2020 | $43.8M | +19.1% |
| FY2019 | $36.7M | +18.3% |
| FY2018 | $31.1M | +27.2% |
| FY2017 | $24.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTXR financial trends
CTXR RevenueCTXR Net incomeCTXR Net marginCTXR Gross profitCTXR Gross marginCTXR Operating incomeCTXR Operating marginCTXR Operating cash flowCTXR Free cash flowCTXR Capital expendituresCTXR Return on equityCTXR Stock buybacksCTXR Dividends paidCTXR Total liabilitiesCTXR Shareholders’ equityCTXR overview →